Martin Shkreli has resigned his position as CEO of Turing Pharmaceuticals in order to become a freelance asshole. / NEPA Scene
The Baffler,  December 18, 2015

Daily Bafflements

Martin Shkreli has resigned his position as CEO of Turing Pharmaceuticals in order to become a freelance asshole. / NEPA Scene
w
o
r
d

f
a
c
t
o
r
y

• After being arrested for what the FBI is calling a “securities fraud trifecta of lies, deceit and greed,” pharma-bro Martin Shkreli stepped down today from his role as CEO of Turing pharmaceuticals. The intelligence agency compared Shkreli’s business model to a Ponzi scheme, just days after Bloomberg Business Week lauded him as a brilliant short seller. The fate of his price-gouging pharmaceutical companies, and that of the rare Wu-Tang Clan album he recently purchased, remains uncertain, but as our own Chris Lehmann points out, the charges are unlikely to do lasting damage.

• In the wake of Chris Lehmann’s column on the mainstream media’s gun-saturated news coverage, we’re revisiting Alex Pareene’s Baffler no. 21 salvo on “D.C.-based access journalism and the highly toxic, incestuous variant of it that Politico has perfected.”

• Last but certainly not least, Wired ominously warns that the Federal Reserve is about to bring about “a unicorn reckoning.” Read it and weep.

You Might Also Enjoy

You Are Not a Rebel

Laurie Penny

The new far right has recognized the enduring appeal of adventurism and appropriated its rhetoric for reactionary ends. 

word factory

Plunged Into Darkness

Sarah Jaffe

Welcome to Interviews for Resistance. We’re now several months into the Trump administration, and activists have scored some. . .

word factory

Non-Compete Clause

Laurie Penny

Female competition is the sharp edge of internalized sexism and the death of solidarity---and it’s utterly, irredeemably neoliberal. 

word factory

Baffler Newsletter

new email subscribers receive a digital copy of our current issue.

Further Reading